skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 249  for All Library Resources

Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Plasma biomarkers for predicting the development of dementia in a community‐dwelling older Japanese population
Material Type:
Article
Add to My Research

Plasma biomarkers for predicting the development of dementia in a community‐dwelling older Japanese population

Psychiatry and clinical neurosciences, 2024-06, Vol.78 (6), p.362-371 [Peer Reviewed Journal]

2024 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology. ;2024 The Authors. Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology. ;2024. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1323-1316 ;EISSN: 1440-1819 ;DOI: 10.1111/pcn.13661 ;PMID: 38606661

Full text available

2
Seven‐plus hours of daily sedentary time and the subsequent risk of breast cancer: Japan Multi‐Institutional Collaborative Cohort Study
Material Type:
Article
Add to My Research

Seven‐plus hours of daily sedentary time and the subsequent risk of breast cancer: Japan Multi‐Institutional Collaborative Cohort Study

Cancer science, 2024-02, Vol.115 (2), p.611-622 [Peer Reviewed Journal]

2023 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.16020 ;PMID: 38041484

Full text available

3
Brigatinib in Japanese patients with ALK‐positive non‐small‐cell lung cancer: Final results of the phase 2 J‐ALTA trial
Material Type:
Article
Add to My Research

Brigatinib in Japanese patients with ALK‐positive non‐small‐cell lung cancer: Final results of the phase 2 J‐ALTA trial

Cancer science, 2023-09, Vol.114 (9), p.3698-3707 [Peer Reviewed Journal]

2023 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15888 ;PMID: 37434391

Full text available

4
Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non‐small‐cell lung cancer in KEYNOTE‐407
Material Type:
Article
Add to My Research

Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non‐small‐cell lung cancer in KEYNOTE‐407

Cancer science, 2023-08, Vol.114 (8), p.3330-3341 [Peer Reviewed Journal]

2023 Merck Sharp & Dohme LLC and The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023 Merck Sharp & Dohme LLC and The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15816 ;PMID: 37183528

Full text available

5
Style changes before and after disease onset in the works of an ikebana (Japanese traditional flower arrangement) artist with semantic variant primary progressive aphasia
Material Type:
Article
Add to My Research

Style changes before and after disease onset in the works of an ikebana (Japanese traditional flower arrangement) artist with semantic variant primary progressive aphasia

Psychiatry and clinical neurosciences, 2023-08, Vol.77 (8), p.460-461 [Peer Reviewed Journal]

2023 The Authors. Psychiatry and Clinical Neurosciences © 2023 Japanese Society of Psychiatry and Neurology. ;2023 Japanese Society of Psychiatry and Neurology ;ISSN: 1323-1316 ;EISSN: 1440-1819 ;DOI: 10.1111/pcn.13571 ;PMID: 37254948

Full text available

6
Genomic landscape and its prognostic significance in stage III colorectal cancer: JCOG1506A1, an ancillary of JCOG0910
Material Type:
Article
Add to My Research

Genomic landscape and its prognostic significance in stage III colorectal cancer: JCOG1506A1, an ancillary of JCOG0910

Cancer science, 2023-08, Vol.114 (8), p.3352-3363 [Peer Reviewed Journal]

2023 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15834 ;PMID: 37189003

Full text available

7
Body mass index and esophageal and gastric cancer: A pooled analysis of 10 population‐based cohort studies in Japan
Material Type:
Article
Add to My Research

Body mass index and esophageal and gastric cancer: A pooled analysis of 10 population‐based cohort studies in Japan

Cancer science, 2023-07, Vol.114 (7), p.2961-2972 [Peer Reviewed Journal]

2023 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15805 ;PMID: 37013939

Full text available

8
Phylogenic position and low genomic diversity of “Candidatus Rickettsia kotlanii” inferred by complete genome sequences of two Japanese isolates
Material Type:
Article
Add to My Research

Phylogenic position and low genomic diversity of “Candidatus Rickettsia kotlanii” inferred by complete genome sequences of two Japanese isolates

Microbiology and immunology, 2023-06, Vol.67 (6), p.275-280 [Peer Reviewed Journal]

2023 The Authors. published by The Societies and John Wiley & Sons Australia, Ltd. ;2023 The Authors. Microbiology and Immunology published by The Societies and John Wiley & Sons Australia, Ltd. ;2023. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0385-5600 ;EISSN: 1348-0421 ;DOI: 10.1111/1348-0421.13065 ;PMID: 36994930

Full text available

9
Molecular pathology quality control in Southeast Asia: Results of a multiregional quality assurance study from MASTER KEY Asia
Material Type:
Article
Add to My Research

Molecular pathology quality control in Southeast Asia: Results of a multiregional quality assurance study from MASTER KEY Asia

Cancer science, 2023-06, Vol.114 (6), p.2664-2673 [Peer Reviewed Journal]

2023 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15790 ;PMID: 36919757

Full text available

10
Language patterns in Japanese patients with Alzheimer disease: A machine learning approach
Material Type:
Article
Add to My Research

Language patterns in Japanese patients with Alzheimer disease: A machine learning approach

Psychiatry and clinical neurosciences, 2023-05, Vol.77 (5), p.273-281 [Peer Reviewed Journal]

2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology. ;2022 The Authors. Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology. ;2022. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1323-1316 ;EISSN: 1440-1819 ;DOI: 10.1111/pcn.13526 ;PMID: 36579663

Full text available

11
Disparities among Japanese municipalities in recommendations for routine and catch‐up HPV vaccinations
Material Type:
Article
Add to My Research

Disparities among Japanese municipalities in recommendations for routine and catch‐up HPV vaccinations

Cancer science, 2023-05, Vol.114 (5), p.2139-2144 [Peer Reviewed Journal]

2023 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15748 ;PMID: 36747329

Full text available

12
Phase 1 trial of zolbetuximab in Japanese patients with CLDN18.2+ gastric or gastroesophageal junction adenocarcinoma
Material Type:
Article
Add to My Research

Phase 1 trial of zolbetuximab in Japanese patients with CLDN18.2+ gastric or gastroesophageal junction adenocarcinoma

Cancer science, 2023-04, Vol.114 (4), p.1606-1615 [Peer Reviewed Journal]

2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15684 ;PMID: 36478334

Full text available

13
Anxiety, depression, and posttraumatic stress symptoms of Japanese nationals half a year after the 2022 conflict in Ukraine
Material Type:
Article
Add to My Research

Anxiety, depression, and posttraumatic stress symptoms of Japanese nationals half a year after the 2022 conflict in Ukraine

Psychiatry and clinical neurosciences, 2023-03, Vol.77 (3), p.190-191 [Peer Reviewed Journal]

2022 The Authors Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology ;2022. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1323-1316 ;EISSN: 1440-1819 ;DOI: 10.1111/pcn.13507 ;PMID: 36370054

Full text available

14
Cusatuzumab plus azacitidine in Japanese patients with newly diagnosed acute myeloid leukemia ineligible for intensive treatment
Material Type:
Article
Add to My Research

Cusatuzumab plus azacitidine in Japanese patients with newly diagnosed acute myeloid leukemia ineligible for intensive treatment

Cancer science, 2023-03, Vol.114 (3), p.1037-1044 [Peer Reviewed Journal]

2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15663 ;PMID: 36394119

Full text available

15
Mitochondrial DNA haplogroup M7: A predictor of poor prognosis for colorectal cancer patients in Chinese population
Material Type:
Article
Add to My Research

Mitochondrial DNA haplogroup M7: A predictor of poor prognosis for colorectal cancer patients in Chinese population

Cancer science, 2023-03, Vol.114 (3), p.1056-1066 [Peer Reviewed Journal]

2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15654 ;PMID: 36382493

Full text available

16
Phase I study of the irreversible fibroblast growth factor receptor 1–4 inhibitor futibatinib in Japanese patients with advanced solid tumors
Material Type:
Article
Add to My Research

Phase I study of the irreversible fibroblast growth factor receptor 1–4 inhibitor futibatinib in Japanese patients with advanced solid tumors

Cancer science, 2023-02, Vol.114 (2), p.574-585 [Peer Reviewed Journal]

2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15486 ;PMID: 35838190

Full text available

17
Japanese nationwide observational multicenter study of tumor BRCA1/2 variant testing in advanced ovarian cancer
Material Type:
Article
Add to My Research

Japanese nationwide observational multicenter study of tumor BRCA1/2 variant testing in advanced ovarian cancer

Cancer science, 2023-01, Vol.114 (1), p.271-280 [Peer Reviewed Journal]

2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;COPYRIGHT 2023 John Wiley & Sons, Inc. ;2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15518 ;PMID: 36254756

Full text available

18
Abemaciclib plus fulvestrant in East Asian women with HR+, HER2− advanced breast cancer: Overall survival from MONARCH 2
Material Type:
Article
Add to My Research

Abemaciclib plus fulvestrant in East Asian women with HR+, HER2− advanced breast cancer: Overall survival from MONARCH 2

Cancer science, 2023-01, Vol.114 (1), p.221-226 [Peer Reviewed Journal]

2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;COPYRIGHT 2023 John Wiley & Sons, Inc. ;2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15600 ;PMID: 36168844

Full text available

19
p53 Arg72Pro polymorphism, adiposity status, and cancer risk: Two case‐cohorts within a Japanese prospective study
Material Type:
Article
Add to My Research

p53 Arg72Pro polymorphism, adiposity status, and cancer risk: Two case‐cohorts within a Japanese prospective study

Cancer science, 2022-12, Vol.113 (12), p.4385-4393 [Peer Reviewed Journal]

2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15572 ;PMID: 36083231

Full text available

20
Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE‐1 (phase 2) Japanese cohort
Material Type:
Article
Add to My Research

Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE‐1 (phase 2) Japanese cohort

Cancer science, 2022-12, Vol.113 (12), p.4267-4276 [Peer Reviewed Journal]

2022 Janssen Research and Development, LLC. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022 Janssen Research and Development, LLC. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15556 ;PMID: 36052883

Full text available

Results 1 - 20 of 249  for All Library Resources

Results 1 2 3 4 5 next page

Searching Remote Databases, Please Wait